Literature DB >> 4128169

Immunosuppressive factors released by transforming lymphocytes in the delayed hypersensitivity skin response to tuberculin.

P M Outteridge, A W Lepper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4128169      PMCID: PMC1423000     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  23 in total

1.  The depression of the immune response by serum protein fractions.

Authors:  F H Sims; J W Freeman
Journal:  Immunology       Date:  1966-09       Impact factor: 7.397

2.  Transformation of human lymphocytes: inhibition by homologous alpha globulin.

Authors:  S R Cooperband; H Bondevik; K Schmid; J A Mannick
Journal:  Science       Date:  1968-03-15       Impact factor: 47.728

3.  Induction of DNA synthesis in normal human lymphocyte cultures by antigen-antibody complexes.

Authors:  G Möller
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

4.  Interaction between 'sensitized lymphocytes' and antigen in vitro. I. The release of a skin reactive factor.

Authors:  E Pick; J Krejci; K Cech; J L Turk
Journal:  Immunology       Date:  1969-11       Impact factor: 7.397

5.  Lymphocyte in vitro cytotoxicity: correlation of derepression with release of lymphotoxin from human lymphocytes.

Authors:  T W Williams; G A Granger
Journal:  J Immunol       Date:  1969-08       Impact factor: 5.422

6.  "Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation.

Authors:  D C Dumonde; R A Wolstencroft; G S Panayi; M Matthew; J Morley; W T Howson
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

7.  Use of Carbowax as a high molecular weight nonprotein substance for cultivation of lymphoid cells and study of their morphology.

Authors:  M Pospisil
Journal:  Folia Microbiol (Praha)       Date:  1967       Impact factor: 2.099

8.  Selective and specific inhibition of 24 hour skin reactions in the guinea-pig. I. Immune deviation: description of the phenomenon and the effect of splenectomy.

Authors:  G L Asherson; S H Stone
Journal:  Immunology       Date:  1965-09       Impact factor: 7.397

9.  Inhibition of tuberculin-induced mitogenesis in cultures of lymphocytes from tuberculous donors.

Authors:  D H Heilman; W McFarland
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

10.  Suppression of delayed hypersensitivity by antigen and antibody. Is a common precursor cell responsible for both delayed hypersensitivity and antibody formation?

Authors:  M A Axelrad
Journal:  Immunology       Date:  1968-08       Impact factor: 7.397

View more
  7 in total

1.  Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Guérin.

Authors:  A P van der Meijden; P A Steerenberg; I M van Hoogstraaten; J A Kerckhaert; L M Schreinemachers; E J Harthoorn-Lasthuizen; A M Hagenaars; W H de Jong; F M Debruijne; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Antibody and cell-mediated immunity in rabbits infected with the larval stages of Taenia pisiformis.

Authors:  M D Rickard; P M Outteridge
Journal:  Z Parasitenkd       Date:  1974

3.  Temporary suppression of lymphocyte transformation after tuberculin skin testing.

Authors:  K Thestrup-Pedersen
Journal:  Immunology       Date:  1974-12       Impact factor: 7.397

Review 4.  Mycobacterium.

Authors:  L Barksdale; K S Kim
Journal:  Bacteriol Rev       Date:  1977-03

5.  Specific immune responses to skin test antigens following repeated multiple antigen skin tests in normal individuals.

Authors:  B Lesourd; W D Winters
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

6.  Association of sepsis with an immunosuppressive polypeptide in the serum of burn patients.

Authors:  M B Constantian
Journal:  Ann Surg       Date:  1978-08       Impact factor: 12.969

7.  Immune reactivity in cattle with ocular squamous cell carcinoma after intralesional BCG immunotherapy.

Authors:  W R Klein; P A Steerenberg; F Poelma; E vd Wiel; V P Rutten; W Misdorp; W H de Jong; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.